NCT03934281 (MELIDIAB) is a NA clinical trial of Honey dressing Melectis G in Diabete Mellitus, sponsored by Centre Hospitalier Metropole Savoie.

Who is sponsoring NCT03934281?

NCT03934281 is sponsored by Centre Hospitalier Metropole Savoie.

What drugs are being tested in NCT03934281?

Interventions in NCT03934281: Honey dressing Melectis G, HAS recommendation dressing.

What condition does NCT03934281 study?

NCT03934281 studies Diabete Mellitus, Amputation, Amputation Wound, Toe (Toes); Wound.

Is NCT03934281 still recruiting?

NCT03934281 is currently completed. Last updated 22 June 2022.

Last reviewed 2022-06-22 · How we verify

NCT03934281: MELIDIAB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of the Value of Using a Honey Dressing Compared to the Use of a Standard Dressing on the Toe Amputation Wound in the Diabetic Patient

Completed NA Last updated 22 June 2022

What this trial tests

NA trial testing Honey dressing Melectis G in Diabete Mellitus in 24 participants. Completed in 8 February 2021.

Timeline

27 June 2018

Primary endpoint
8 February 2021

8 February 2021

Quick facts

Lead sponsor	Centre Hospitalier Metropole Savoie
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	24
Start date	27 June 2018
Primary completion	8 February 2021
Estimated completion	8 February 2021
Sites	1 location across France

Drugs / interventions tested

Honey dressing Melectis G
HAS recommendation dressing

Conditions studied

Diabete Mellitus — all drugs for Diabete Mellitus →
Amputation — all drugs for Amputation →
Amputation Wound — all drugs for Amputation Wound →
Toe (Toes); Wound — all drugs for Toe (Toes); Wound →

Sponsor

Centre Hospitalier Metropole Savoie

Who can join

18 and older, any sex, with Diabete Mellitus or Amputation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Numerous scientific publications in France and internationally have described the healing, anti-bacterial, anti-oxidant, anti-inflammatory and immuno-modulating properties of honey. Honey is effective in the management of many infected or uninfected post-surgical wounds. This study focuses on post surgical wounds after toe amputation in diabetic patients. The main objective of this study is to compare the rate of epidermisation at six months for these wounds, between honey dressing and other dressing devices used according to the french Haute Autorité de Santé (HAS) recommendations

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Therapies and delivery systems for diabetic wound care: current insights and future directions.
Yadav PS, Singh M, Vinayagam R, Shukla P. · · 2025 · cited 5× · PMID 40766758 · DOI 10.3389/fphar.2025.1628252

Verify or expand the search:

Other recruiting trials for Diabete Mellitus

Currently open trials in the same condition.

NCT07378956 — Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus · NA · recruiting
NCT07432893 — Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts · NA · recruiting
NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
NCT07293156 — Impact of Pilates Exercises on Diabetic Erectile Dysfunction. · NA · recruiting
NCT07496593 — Total Intravenous and Balanced Anesthesia in Diabetic Patients Undergoing Video-Assisted Thoracoscopy · Phase 4 · active not recruiting

Other Centre Hospitalier Metropole Savoie trials

Trials by the same sponsor.

NCT07354607 — Effect of Transcutaneous Electrical Stimulation on Peripheral Blood Flow · NA · recruiting
NCT07172984 — The Value of Standardized Respiratory Rate Monitoring Exercises During Rheumatological Injection Procedures · NA · recruiting
NCT06951893 — Identification of Pre-surgical Phenotypic Indicators Predictive of Quality of Life Trajectories in Obese Patients Follow · NA · not yet recruiting
NCT06921226 — Exploratory Analysis of Interpersonal and Intrapersonal Psychological Processes Implied in Risk-taking and Suicidal Beha · NA · not yet recruiting
NCT06847152 — Spatial Memory and Temporal Lobe Epilepsy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03934281 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Metropole Savoie
Last refreshed: 22 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03934281.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing